Tirzepatide reduces overall mortality in people with type 2 diabetes
medicine Friday, August 16, 2024 Tainan – According to a new cohort study, the dual agonist tirzepatide reduces the overall mortality of people with type 2 diabetes compared to glucagon-like peptide 1 receptor agonists (GLP-1-RA).